Welcome to our dedicated page for Haleon SEC filings (Ticker: HLN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Haleon’s separation from GSK created a consumer-health giant with dozens of power brands—and a web of disclosures that can overwhelm even seasoned analysts. Sales are broken out across oral care, pain relief, vitamins and more, while its first standalone Form 20-F runs hundreds of IFRS-heavy pages. If you have ever asked, "Where do I find Haleon insider trading Form 4 transactions" or "How do I decode Haleon’s quarterly earnings report 10-Q filing?", you know the challenge.
Stock Titan solves it. Our AI reads every new filing the moment it hits EDGAR, then delivers plain-English summaries, red-flags and searchable key terms. Whether you need Haleon Form 4 insider transactions in real-time, a side-by-side view of segment revenue from the latest 6-K, or want Haleon SEC filings explained simply, the platform highlights what matters: advertising spend trends, litigation provisions, post-spin debt covenants and more. Long-tail queries such as "Haleon executive stock transactions Form 4", "understanding Haleon SEC documents with AI", or "Haleon earnings report filing analysis" resolve to the exact section—no scrolling required.
All filing types are here, updated continuously: the Haleon annual report 10-K simplified (20-F), Haleon proxy statement executive compensation, and every Haleon 8-K material events explained. Use our tools to:
- Track insider buying and selling before marketing launches
- Compare vitamin and mineral supplement growth quarter-over-quarter
- Spot supply-chain disclosures in material event filings
Haleon plc announced on 29 September 2025 that it purchased 1,996,340 ordinary shares of £0.01 each under the second tranche of its share buyback programme announced 31 July 2025. Trades executed on the London Stock Exchange/CBOE (UK)/CXE on 26 September 2025 show prices reported between £325.1000 and £328.7000 with an average of £327.6614. The Company intends to hold the purchased shares as treasury shares. After settlement, registered share capital is 8,952,353,648 ordinary shares, of which 40,904,443 are treasury shares, leaving 8,911,449,205 ordinary shares with voting rights. A full trade breakdown is available via the provided RNS link and the Company website.
Haleon plc filed a Form 6-K reporting a notification of transactions by persons discharging managerial responsibilities (PDMRs) under the UK Market Abuse Regulation. The notice, dated
Haleon plc reports a purchase of 2,318,700 ordinary shares under the second tranche of its share buyback programme. The trades occurred on the London Stock Exchange/CBOE (UK)/CXE on 25 September 2025 with reported trade price points shown as 329.7000, 325.9000 and a weighted average of 327.8536. The Company intends to hold the purchased shares as treasury shares. After settlement, registered share capital is 8,952,353,648 ordinary shares of £0.01 each, of which 38,908,103 are held as treasury shares, leaving 8,913,445,545 ordinary shares with voting rights. A full breakdown of individual trades is available via the provided RNS link and on the Company website.
Haleon plc announced on 25 September 2025 the purchase of 3,251,858 ordinary shares of £0.01 each under the second tranche of its share buyback programme announced 31 July 2025. The purchases included 3,101,999 shares executed on 24 September 2025 on the London Stock Exchange CBOE (UK)/CXE at an average price of £330.4723 per share as shown in the trade breakdown. The Company intends to hold the acquired shares as treasury shares. After settlement the registered share capital is 8,952,353,648 ordinary shares, of which 36,589,403 are treasury shares, leaving 8,915,764,245 ordinary shares with voting rights for FCA disclosure guidance purposes. A full breakdown of individual trades is available at the provided RNS link and on the Company website.
Haleon plc (HLN) published a TR-1 notification reporting a significant shareholding held by Wellington Management group entities. The notification shows 418,575,113 direct voting rights, representing 4.69% of the company's voting rights. In addition, financial instruments reported in the notice amount to 26,175,050 voting rights (sub‑totals listed under 8.B1 and 8.B2), producing a total reported interest of 4.98% when instruments are included. The filing lists multiple Wellington controlled undertakings and indicates the chains of ownership through Wellington Management Group LLP and its affiliates that manage assets for funds and managed accounts. The disclosure is provided under the FCA/DTR rules as required for major holdings.
Haleon plc announced the purchase of 5,150,000 ordinary shares of £0.01 each on 23 September 2025 as part of the second tranche of its share buyback programme. The company intends to hold the purchased shares as treasury shares.
After settlement, registered share capital is 8,952,353,648 ordinary shares, of which 33,337,545 are treasury shares, leaving 8,919,016,103 ordinary shares with voting rights. The announcement includes a link to a full breakdown of individual trades and clarifies it is not an offer for securities.
Haleon plc announced the purchase of 5,150,000 ordinary shares under the second tranche of its share buyback programme. The Company intends to hold the purchased shares as treasury shares. After settlement, registered share capital is 8,952,353,648 ordinary shares of £0.01 each, of which 28,187,545 are held as treasury shares, leaving 8,924,166,103 ordinary shares with voting rights. A full breakdown of individual trades is available via the provided London Stock Exchange link and on the Company website.
Haleon plc announced the purchase of 4,150,000 ordinary shares of £0.01 each on 19 September 2025 under the second tranche of its share buyback programme announced 31 July 2025. The shares were purchased on the London Stock Exchange and CBOE (UK)/CXE across the session; a full breakdown of individual trades is provided via the Company link. The Company intends to hold the purchased shares as treasury shares. After settlement, registered share capital is 8,952,353,648 ordinary shares, of which 23,037,545 are treasury shares, leaving 8,929,316,103 voting shares.
Haleon plc reports it purchased 4,314,000 ordinary shares of £0.01 each under the second tranche of its buyback programme announced 31 July 2025. The company intends to hold the purchased shares as treasury shares. After settlement the company's registered share capital is 8,952,353,648 ordinary shares, of which 18,887,545 are treasury shares, leaving 8,933,466,103 ordinary shares with voting rights. Shareholders may use the voting-rights figure to determine notification obligations under the FCA Disclosure Guidance and Transparency Rules. A full breakdown of individual trades is available via the provided RNS link and on the company website.
FAQ
What is the current stock price of Haleon (HLN)?
What is the market cap of Haleon (HLN)?
